360iResearch Logo
Global Clinical Trials Market
Report Code: MRR-DA05154 | Publishing Date: May 2020 | Number of Pages: 162
Global Clinical Trials Market | Market Research Report | Cumulative Impact of COVID-19

Market Dynamics:

The factors attributing to the growth of the market are shift towards patient centric clinical trials, rising prevalence of diseases, and improved clinical trails due to cro consolidation. However, some factors such as dearth of skilled clinical research professional and rising cost of clinical trials may hinder the market growth. The Clinical Trials Market is expected to showcase the opportunities such as demand for clinical trials in the emerging economies and high r&d expenditure by the pharmaceutical industry. In the near future market may face the possible challenges in the growth due to stringent regulations for patient enrollment. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the Clinical Trials Market.

Market Segmentation & Coverage:

The research report categorizes the Clinical Trials Market to forecast the revenues and analyze the trends in each of the following segments:

"The Treatment Study is projected to witness the highest growth during the forecast period"

On the basis of Design, the Clinical Trials Market is studied across Observational Study and Treatment Study. The Observational Study further studied across Case Control Study, Cohort Study, Cross Sectional Study, and Ecological Study. The Treatment Study further studied across Adaptive Clinical Trial, Non-randomized Control Trial, and Randomized Control Trial. The Observational Study commanded the largest size in the Clinical Trials Market in 2019, followed by the Treatment Study. On the other hand, the Treatment Study is expected to grow at the fastest CAGR during the forecast period.

"The Phase II is projected to witness the highest growth during the forecast period"

On the basis of Phase, the Clinical Trials Market is studied across Phase I, Phase II, Phase III, and Phase IV. The Phase III commanded the largest size in the Clinical Trials Market in 2019, followed by the Phase II. On the other hand, the Phase II is expected to grow at the fastest CAGR during the forecast period.

"The Oncology is projected to witness the highest growth during the forecast period"

On the basis of Indication, the Clinical Trials Market is studied across Autoimmune/Inflammation, CNS condition, Cardiovascular, Diabetes, Obesity, Oncology, and Pain management. The Autoimmune/Inflammation commanded the largest size in the Clinical Trials Market in 2019, followed by the Oncology. On the other hand, the Oncology is expected to grow at the fastest CAGR during the forecast period.

On the basis of Geography, the Clinical Trials Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The Clinical Trials Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increasing competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Trials Market including Charles River Laboratory, Chiltern International Ltd., Clinipace, Eli Lilly and Company, ICON PLC, IQVIA, Novo Nordisk A/S, PAREXEL International Corporation, Pfizer Inc., Pharmaceutical Product Development, LLC, PRA Health Sciences, SGS SA, Syneos Health, and Wuxi AppTec Inc..

Scope of the Report:

AttributeDetails
Base Year for Estimation2019
Historical Period2017 - 2018
Estimation Period2020 - 2021
Forecast Year2025
Market RepresentationRevenue in USD Million
Report CoverageRevenue Forecast, Company Share, Competitive Landscape, and Industry Trends.
Customization ScopeIf you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization. We offer 20% free customization which is equivalent to 5 analysts working days.

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of the Clinical Trials Market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the Clinical Trials Market that will impact the demand during the forecast period. Moreover, the competitive analysis of the Clinical Trials Market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview, strategy, and SWOT analysis of the key companies in the market.

Reasons to Buy:

The Clinical Trials Market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the Clinical Trials Market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

  • Evaluate the qualitative and quantitative aspects of the report and analyze the Clinical Trials Market penetration with respect to industries and geographies.
  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the Clinical Trials Market.
  • Evaluate the key vendors in the Clinical Trials Market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Research Process
      1. Define: Research Objective
      2. Determine: Research Design
      3. Prepare: Research Instrument
      4. Collect: Data Source
      5. Analyze: Data Interpretation
      6. Formulate: Data Verification
      7. Publish: Research Report
    2. Research Execution
      1. Initiation: Research Process
      2. Planning: Develop Research Plan
      3. Execution: Conduct Research
      4. Verification: Finding & Analysis
      5. Publication: Research Report
    3. Research Outcome
      1. 360iResearch Market Share Analysis
      2. 360iResearch Competitive Strategic Window
  3. Executive Summary
    1. Market Outlook
    2. Design Outlook
    3. Phase Outlook
    4. Indication Outlook
    5. Geography Outlook
    6. Competitor Outlook
  4. Market Overview
    1. Introduction
    2. Clinical Trials Market, By Geography
  5. Market Dynamics
    1. Introduction
      1. Drivers
        1. Rising prevalence of diseases
        2. Shift towards patient centric clinical trials
        3. Improved clinical trails due to CRO consolidation
      2. Restraints
        1. Dearth of skilled clinical research professional
        2. Rising cost of clinical trials
      3. Opportunities
        1. Demand for clinical trials in the emerging economies
        2. High R&D expenditure by the pharmaceutical industry
      4. Challenges
        1. Stringent regulations for patient enrollment
  6. Market Insights
    1. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    2. Cumulative Impact of COVID-19
    3. Client Customizations
  7. Global Clinical Trials Market, By Design
    1. Introduction
    2. Observational Study
      1. Case Control Study
      2. Cohort Study
      3. Cross Sectional Study
      4. Ecological Study
    3. Treatment Study
      1. Adaptive Clinical Trial
      2. Non-randomized Control Trial
      3. Randomized Control Trial
  8. Global Clinical Trials Market, By Phase
    1. Introduction
    2. Phase I
    3. Phase II
    4. Phase III
    5. Phase IV
  9. Global Clinical Trials Market, By Indication
    1. Introduction
    2. Autoimmune/Inflammation
    3. CNS condition
    4. Cardiovascular
    5. Diabetes
    6. Obesity
    7. Oncology
    8. Pain management
  10. Americas Clinical Trials Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  11. Asia-Pacific Clinical Trials Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. South Korea
    10. Thailand
  12. Europe, Middle East & Africa Clinical Trials Market
    1. Introduction
    2. France
    3. Germany
    4. Italy
    5. Netherlands
    6. Qatar
    7. Russia
    8. Saudi Arabia
    9. South Africa
    10. Spain
    11. United Arab Emirates
    12. United Kingdom
  13. Competitive Landscape
    1. 360iResearch FPNV Positioning Matrix
      1. Quadrants
      2. Business Strategy
      3. Product Satisfaction
    2. 360iResearch Market Ranking Analysis
    3. 360iResearch Market Share Analysis
    4. Competitive Scenario
      1. Merger & Acquisition
      2. Agreement, Collaboration & Partnership
      3. New Product Launch & Enhancement
      4. Investment & Funding
  14. Company Usability Profiles
    1. Charles River Laboratory
    2. Chiltern International Ltd.
    3. Clinipace
    4. Eli Lilly and Company
    5. ICON PLC
    6. IQVIA
    7. Novo Nordisk A/S
    8. PAREXEL International Corporation
    9. Pfizer Inc.
    10. Pharmaceutical Product Development, LLC
    11. PRA Health Sciences
    12. SGS SA
    13. Syneos Health
    14. Wuxi AppTec Inc.
  15. Appendix
    1. Discussion Guide
    2. Edition Details
    3. License Details
    4. Pricing Details

List of Tables

  1. GLOBAL CLINICAL TRIALS MARKET SIZE, 2017-2025 (USD MILLION)
  2. GLOBAL CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  3. GLOBAL CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  4. GLOBAL CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  5. GLOBAL CLINICAL TRIALS MARKET SIZE, BY CASE CONTROL STUDY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  6. GLOBAL CLINICAL TRIALS MARKET SIZE, BY COHORT STUDY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  7. GLOBAL CLINICAL TRIALS MARKET SIZE, BY CROSS SECTIONAL STUDY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  8. GLOBAL CLINICAL TRIALS MARKET SIZE, BY ECOLOGICAL STUDY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  9. GLOBAL CLINICAL TRIALS MARKET SIZE, BY TREATMENT STUDY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  10. GLOBAL CLINICAL TRIALS MARKET SIZE, BY ADAPTIVE CLINICAL TRIAL, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  11. GLOBAL CLINICAL TRIALS MARKET SIZE, BY NON-RANDOMIZED CONTROL TRIAL, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  12. GLOBAL CLINICAL TRIALS MARKET SIZE, BY RANDOMIZED CONTROL TRIAL, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  13. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  14. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  15. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  16. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  17. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE IV, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  18. GLOBAL CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  19. GLOBAL CLINICAL TRIALS MARKET SIZE, BY AUTOIMMUNE/INFLAMMATION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  20. GLOBAL CLINICAL TRIALS MARKET SIZE, BY CNS CONDITION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  21. GLOBAL CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  22. GLOBAL CLINICAL TRIALS MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  23. GLOBAL CLINICAL TRIALS MARKET SIZE, BY OBESITY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  24. GLOBAL CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  25. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PAIN MANAGEMENT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  26. AMERICAS CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  27. AMERICAS CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  28. AMERICAS CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  29. AMERICAS CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  30. ARGENTINA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  31. ARGENTINA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  32. ARGENTINA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  33. BRAZIL CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  34. BRAZIL CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  35. BRAZIL CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  36. CANADA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  37. CANADA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  38. CANADA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  39. MEXICO CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  40. MEXICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  41. MEXICO CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  42. UNITED STATES CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  43. UNITED STATES CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  44. UNITED STATES CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  45. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  46. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  47. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  48. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  49. AUSTRALIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  50. AUSTRALIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  51. AUSTRALIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  52. CHINA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  53. CHINA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  54. CHINA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  55. INDIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  56. INDIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  57. INDIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  58. INDONESIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  59. INDONESIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  60. INDONESIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  61. JAPAN CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  62. JAPAN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  63. JAPAN CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  64. MALAYSIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  65. MALAYSIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  66. MALAYSIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  67. PHILIPPINES CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  68. PHILIPPINES CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  69. PHILIPPINES CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  70. SOUTH KOREA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  71. SOUTH KOREA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  72. SOUTH KOREA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  73. THAILAND CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  74. THAILAND CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  75. THAILAND CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  76. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  77. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  78. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  79. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  80. FRANCE CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  81. FRANCE CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  82. FRANCE CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  83. GERMANY CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  84. GERMANY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  85. GERMANY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  86. ITALY CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  87. ITALY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  88. ITALY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  89. NETHERLANDS CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  90. NETHERLANDS CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  91. NETHERLANDS CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  92. QATAR CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  93. QATAR CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  94. QATAR CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  95. RUSSIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  96. RUSSIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  97. RUSSIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  98. SAUDI ARABIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  99. SAUDI ARABIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  100. SAUDI ARABIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  101. SOUTH AFRICA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  102. SOUTH AFRICA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  103. SOUTH AFRICA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  104. SPAIN CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  105. SPAIN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  106. SPAIN CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  107. UNITED ARAB EMIRATES CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  108. UNITED ARAB EMIRATES CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  109. UNITED ARAB EMIRATES CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  110. UNITED KINGDOM CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  111. UNITED KINGDOM CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  112. UNITED KINGDOM CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  113. GLOBAL CLINICAL TRIALS MARKET: SCORES
  114. GLOBAL CLINICAL TRIALS MARKET: BUSINESS STRATEGY
  115. GLOBAL CLINICAL TRIALS MARKET: PRODUCT SATISFACTION
  116. GLOBAL CLINICAL TRIALS MARKET: RANKING
  117. GLOBAL CLINICAL TRIALS MARKET: MERGER & ACQUISITION
  118. GLOBAL CLINICAL TRIALS MARKET: AGREEMENT, COLLABORATION & PARTNERSHIP
  119. GLOBAL CLINICAL TRIALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  120. GLOBAL CLINICAL TRIALS MARKET: INVESTMENT & FUNDING
  121. GLOBAL CLINICAL TRIALS MARKET: EDITION DETAILS
  122. GLOBAL CLINICAL TRIALS MARKET: LICENSE DETAILS
  123. GLOBAL CLINICAL TRIALS MARKET: PRICING DETAILS

List of Figures

  1. GLOBAL CLINICAL TRIALS MARKET: RESEARCH PROCESS
  2. GLOBAL CLINICAL TRIALS MARKET: RESEARCH EXECUTION
  3. GLOBAL CLINICAL TRIALS MARKET SIZE, 2019 VS 2025 (USD MILLION)
  4. GLOBAL CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2019 VS 2025 (USD MILLION)
  5. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE, 2019 VS 2025 (USD MILLION)
  6. GLOBAL CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2019 VS 2025 (USD MILLION)
  7. GLOBAL CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  8. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CLINICAL TRIALS MARKET, BY TYPE
  9. GLOBAL CLINICAL TRIALS MARKET SIZE, 2017-2025 (USD MILLION)
  10. GLOBAL CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  12. GLOBAL CLINICAL TRIALS MARKET: MARKET DYNAMICS
  13. GLOBAL CLINICAL TRIALS MARKET: PORTERS FIVE FORCES ANALYSIS
  14. GLOBAL CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2019 VS 2025 (USD MILLION)
  15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2025 (USD MILLION)
  16. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE, 2019 VS 2025 (USD MILLION)
  17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE, 2025 (USD MILLION)
  18. GLOBAL CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2019 VS 2025 (USD MILLION)
  19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2025 (USD MILLION)
  20. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  21. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  22. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  23. GLOBAL CLINICAL TRIALS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
  1. Charles River Laboratory
  2. Chiltern International Ltd.
  3. Clinipace
  4. Eli Lilly and Company
  5. ICON PLC
  6. IQVIA
  7. Novo Nordisk A/S
  8. PAREXEL International Corporation
  9. Pfizer Inc.
  10. Pharmaceutical Product Development, LLC
  11. PRA Health Sciences
  12. SGS SA
  13. Syneos Health
  14. Wuxi AppTec Inc.